VIJAYA DIAGNOSTIC CENTRE
|
VIJAYA DIAGNOSTIC CENTRE Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 13.94 | 11.61 | 8.29 | 10.76 | 18.64 |
| CEPS(Rs) | 20.89 | 17.26 | 14.39 | 16.02 | 13.30 |
| DPS(Rs) | 2.00 | 1.00 | 1.00 | 1.00 | - |
| Book NAV/Share(Rs) | 77.32 | 64.09 | 53.18 | 45.73 | 79.04 |
| Tax Rate(%) | 25.56 | 24.61 | 24.93 | 24.91 | 24.08 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 40.10 | 39.74 | 39.64 | 44.05 | 44.05 |
| EBIT Margin(%) | 32.27 | 33.35 | 29.28 | 35.43 | 33.81 |
| Pre Tax Margin(%) | 28.35 | 28.97 | 24.72 | 31.88 | 29.76 |
| PAT Margin (%) | 21.10 | 21.84 | 18.55 | 23.93 | 22.60 |
| Cash Profit Margin (%) | 31.46 | 32.24 | 31.99 | 35.33 | 35.99 |
| Performance Ratios | |||||
| ROA(%) | 12.76 | 13.11 | 11.00 | 17.85 | 16.76 |
| ROE(%) | 19.84 | 19.96 | 16.89 | 26.85 | 26.91 |
| ROCE(%) | 30.27 | 30.40 | 26.53 | 39.37 | 37.97 |
| Asset Turnover(x) | 0.60 | 0.60 | 0.59 | 0.75 | 0.74 |
| Sales/Fixed Asset(x) | 0.59 | 0.59 | 0.66 | 0.90 | 0.91 |
| Working Capital/Sales(x) | 4.71 | 3.96 | 2.19 | 2.27 | 1.93 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.71 | 1.71 | 1.51 | 1.11 | 1.10 |
| Receivable days | 8.30 | 8.57 | 7.65 | 6.50 | 7.12 |
| Inventory Days | 2.71 | 2.41 | 2.51 | 2.73 | 2.62 |
| Payable days | 142.28 | 169.19 | 152.97 | 111.80 | 140.18 |
| Valuation Parameters | |||||
| PER(x) | 72.22 | 54.69 | 47.18 | 40.70 | - |
| PCE(x) | 48.20 | 36.79 | 27.18 | 27.32 | - |
| Price/Book(x) | 13.02 | 9.91 | 7.36 | 9.57 | - |
| Yield(%) | 0.20 | 0.16 | 0.26 | 0.23 | - |
| EV/Net Sales(x) | 15.09 | 11.73 | 8.44 | 9.24 | -0.49 |
| EV/Core EBITDA(x) | 35.28 | 26.58 | 19.76 | 19.73 | -1.04 |
| EV/EBIT(x) | 46.77 | 35.18 | 28.83 | 26.07 | -1.45 |
| EV/CE(x) | 12.92 | 9.78 | 7.12 | 6.06 | -0.51 |
| M Cap / Sales | 15.16 | 11.86 | 8.70 | 9.65 | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 24.39 | 19.29 | -0.68 | 22.73 | 11.19 |
| Core EBITDA Growth(%) | 20.61 | 23.21 | -9.40 | 21.76 | 20.16 |
| EBIT Growth(%) | 20.39 | 35.86 | -17.93 | 28.63 | 28.90 |
| PAT Growth(%) | 20.19 | 40.41 | -23.01 | 30.00 | 36.19 |
| EPS Growth(%) | 20.07 | 40.03 | -22.92 | -42.30 | -86.49 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | 0.01 |
| Current Ratio(x) | 1.89 | 2.90 | 4.17 | 4.08 | 5.40 |
| Quick Ratio(x) | 1.86 | 2.83 | 4.14 | 4.02 | 5.34 |
| Interest Cover(x) | 8.22 | 7.61 | 6.42 | 9.96 | 8.35 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of VIJAYA DIAGNOSTIC CENTRE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIJAYA DIAGNOSTIC CENTRE | ₹10,532.4 Cr | 0.7% | 4.5% | 4% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹107,864.0 Cr | -3.6% | -2.3% | 7.6% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹107,272.0 Cr | -2.1% | -4.6% | 1.2% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹73,181.9 Cr | -4.1% | -8.9% | 58.5% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹35,981.8 Cr | -3.3% | -0.6% | 40.8% | Stock Analytics | |
| GLOBAL HEALTH | ₹31,573.5 Cr | -8.2% | -12.9% | 9.4% | Stock Analytics | |
VIJAYA DIAGNOSTIC CENTRE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIJAYA DIAGNOSTIC CENTRE | 0.7% |
4.5% |
4% |
| SENSEX | 1.2% |
2.8% |
6.3% |
You may also like the below Video Courses
